Camac Fund, LP 4
4 · Pasithea Therapeutics Corp. · Filed Aug 31, 2022
Insider Transaction Report
Form 4
Shahinian Eric
Other
Transactions
- Purchase
Common Stock
2022-08-30$1.15/sh+17,828$20,452→ 1,635,157 total(indirect: See footnote) - Purchase
Common Stock
2022-08-29$1.17/sh+5,000$5,841→ 1,617,329 total(indirect: See footnote)
Footnotes (2)
- [F1]The number of shares beneficially owned includes 1,000 shares inadvertently omitted from the Reporting Persons' Form 3 filed 08/15/2022.
- [F2]The shares are held by Camac Fund, LP. ("Camac Fund"). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC.